|Wiebke Arlt, MD, DSc, FRCP, FMedSci
Institute of Metabolism and Systems Research (IMSR),
University of Birmingham,
UKResearch focus: the role of steroid metabolism in human health and disease, with translational focus on androgen excess and adrenal disease.
|Maria Alevizaki MD, PhD
Professor of Endocrinology,
Athens University School of Medicine,
Clinical and research interests: Thyroid carcinoma; Medullary thyroid carcinoma; Familial thyroid disease; Subclinical thyroid disease and its complications; Endocrine tumours.
|Ernesto Canalis – North America
Professor, Departments of Orthopedic Surgery and Medicine, University of Connecticut Health Center, Hartford, CT, USA
The Canalis' laboratory discovered the existence of skeletal growth factors and his interests centre around growth factors and their antagonists, anabolic agents, and determinants of cell fate, such as Notch.
|Zhengpei Zeng MD – China
Professor of Endocrinology,
Department of Endocrinology,
Peking Union Medical College Hospital (PUMCH), Chinese Academy of Medical Sciences (CAMS), Beijing, China
Professor Zeng is Honorary President of the Chinese Society of Endocrinology. Her clinical research interests include endocrine hypertension, pheochromocytoma, multiple endocrine neoplasia and adrenal diseases.
|Cesar Luiz Boguszewski MD, PhD – South America
Professor of Endocrinology, Endocrine Division (SEMPR), Department of Internal Medicine, Federal University of Parana, Curitiba, Brazil
Research focus: Pituitary diseases, obesity and neuroendocrine body weight regulation.
|Ken Ho MD, FRACP, FRCP – Australasia
Chair, Centres for Health Research, Princess Alexandra Hospital, Brisbane, Australia
Research interests: Pituitary disorders, neuroendocrine regulation of substrate and energy metabolism, endocrinology of sports.
|Marianne Andersen, PhD, DMSci
Professor of Endocrinology, Novo Nordisk foundation, Denmark
Research focus: Pathophysiology and treatment of pituitary diseases (and male hypogonadism).
|Kåre I Birkeland
Head, Department of Endocrinology, Obesity and Preventive Medicine, Oslo University Hospital and Professor of Endocrinology, Faculty of Medicine, University of Oslo, Oslo, Norway
His main research interest is to explore the relationship between environmental factors and the development of insulin resistance and type 2 diabetes and clinical studies exploring the effects of lifestyle and pharmacological interventions on these outcomes.
Head, Department of Endocrinology, Metabolic Diseases and Nutrition, CHU Rangueil-Larrey
His research interests include clinical thyroidology, hypothalamic pituitary diseases, growth disorders and neuroendocrine tumours.
Professor of Medicine at the University of Würzburg, Chairman Division of Endocrinology and Diabetes, University Hospital of Würzburg, Germany
His main research focus is on endocrine tumors with a particular focus on adrenal tumors and adrenal disease in general.
Associate Professor of Endocrinology, Department of Pathophysiology and Transplantation, University of Milan Endocrine Unit, Fondazioen IRCCS Ca’Granda, Milan, Italy
Her main research interests include the molecular basis, clinical and therapeutic aspects of thyroid cancer. Genetics of congenital hypothyroidism.
Associate Professor of Endocrinology, Department of Experimental Medicine, Sapienza University of Rome, Rome, Italy
His main contributions in clinical research are on the syndromes of steroid hormones excess and defect, specifically male hypogonadism, Cushing’s syndrome and adrenal insufficiency.
|Gudmundur Johannsson MD, PhD
Senior Consultant, Department of Endocrinology, Sahlgrenska University Hospital; Professor of Endocrinology, Sahlgrenska Academy, University of Gothenburg, Sweden
His major research interests include pituitary diseases, the importance of growth hormone in adults and adrenal insufficiency.
|Filip K Knop MD, PhD
Consultant Endocrinologist, Professor of Endocrinoloy and Chief of Research, Department of Medicine, Founding Director, Center for Diabetes Research, Gentofte Hospital, University of Copenhagen, Denmark
Prof. Knop's resesearch interest centres on the pathophysiology of type 2 diabetes, obesity, regulation of appetite and food intake, and the therapeutic role of incretins. He is particularly interested in the integrative role of the gut in human (patho)physiology.
Professor, Department of Medicine, University of Montreal, Canada
Research focus: Molecular mechanisms of adrenal tumors, aberrant hormone receptors in adrenal tumours and hyperplasia, new therapies for pituitary and adrenal tumours.
Professor, Consultant, Department of Endocrinology and Internal Medicine THG, Aarhus University Hospital, Denmark
Her research interests include the impact of diabetes on bone health, the effects of vitamins D and K on bone metabolism, and the development of new treatments for osteoporosis.
Professor, Department of Paediatric Endocrinology and Diabetes, Head, Reference Center for Rare Endocrine Growth Diseases, Robert Debré University Hospital, Paris, France
Her research interests include various aspects of thyroid and pituitary diseases management and long-term consequences of intrauterine malnutrition on growth, neurodevelopmental outcome and metabolic disorders.
|José C Moreno MD, PhD
Paediatric Endocrinologist, Scientific researcher, Laboratory Head Thyroid Molecular Laboratory, Institute for Medical and Molecular Genetics (INGEMM), La Paz University Hospital, Madrid, Spain
His research focus is genetics of congenital hypothyroidism.
Niilo Hallman Professor in Translational Pediatrics and Pediatric Endocrinologist at Children's Hospital, University of Helsinki, Helsinki, Finland
His research interest is in pediatric endocrinology with a special focus on mechanisms regulating growth and puberty.
|Antoine Tabarin MD
Professor of Medicine at University of Bordeaux 2, Chairman Division of Endocrinology, University Hospital of Bordeaux, France
His current research focus is in neuroendocrinology and endocrine tumors with a specific focus on adrenal tumors and disease of the HPA axis.
|Jeremy W Tomlinson FRCP, PhD
Professor of Metabolic Endocrinology and Consultant Endocrinologist, Oxford Centre for Diabetes, Endocrinology and Metabolism, University of Oxford, UK
His research focus is obesity, insulin resistance and steroid hormones.
|Jenny Tong MD, MPH
Associate Professor, Division of Endocrinology, Duke Molecular and Physiology Institute, Duke University, USA
Her primary research interest is the regulation of glucose homeostasis and abnormalities that lead to type 2 diabetes. Work in her lab is directed at understanding the role of gut hormone ghrelin in the regulation of glucose metabolism and food intake using a translational approach.
|Corinne Alberti MD, PhD
Professor of Epidemiology, Director of the Clinical Epidemiology Unit, Robert Debré Pediatric Teaching Hospital, University of Paris Diderot - Sorbonne Paris Cité, Assistance Publique des Hopitaux de Paris (AP-HP), Director of the CIE 5, Inserm, Paris, France
Her research focuses on clinical epidemiology in pediatrics.
|Olaf Dekkers MD, PhD, MSc, MA
Endocrinologist and Epidemiologist, Leiden University Medical Center, Netherlands
He is employed at the Departments of Endocrinology and Clinical Epidemiology, Leiden University Medical Center. His research interests are endocrine diseases, meta-analysis and methodology of research. He works in close collaboration with the Institute of Social and Preventive Medicine, Bern, Switzerland and with the Department of Clinical Epidemiology in Aarhus, Denmark.
|Mathieu Molimard MD, PhD
Professor of Clinical Pharmacology at University of Bordeaux, Head of the Pharmacology départment University Hospital of Bordeaux, France
His current research focuses on pharmacology of targeted therapies.
|Peter Nightingale BSc, PhD
Statistician, University Hospitals Birmingham NHS Foundation Trust, Birmingham, UK
He has been Statistician for the Wellcome Trust Clinical Research Facility, Birmingham, since 2001 and provides statistical support to University Hospitals Birmingham and to Dudley Group of Hospitals.
Editors' declarations are listed in the journal's Disclosure Policy.